Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 607, pseudogene (RN7SL607P)

Target
RN7SL607P
Molecular classification
Pseudogene, Non-coding RNA pseudogene, Retrotransposed pseudogene (processed pseudogene), Other
01

Overview

RN7SL607P (RNA, 7SL, cytoplasmic 607, pseudogene) is a human pseudogene derived from the 7SL RNA, which itself is a structural component of the signal recognition particle (SRP) ribonucleoprotein complex[1][5]. As a pseudogene, RN7SL607P does not encode a functional protein and is classified as a non-coding RNA locus that has lost its original gene function, most likely through retrotransposition events resulting in a truncated or non-functional sequence[1][5]. While many 7SL RNA pseudogenes populate the human genome, with diverse truncated structures, only a small number of 7SL loci are functional genes[5]. Most 7SL pseudogenes—including RN7SL607P—are regarded as molecular genetic relics, showing no known protein-coding, therapeutic, or direct pathogenic roles[1][5]. Though increasing evidence links some pseudogenes to gene regulation (e.g., affecting microRNAs or modulating parental gene expression), there is currently no specific evidence for RN7SL607P having such regulatory or clinical roles[1][2]. Therefore, it is not considered a drug target, biomarker, or safety concern[1]. Pseudogenes in general are a subject of emerging interest for their potential regulatory effects, but RN7SL607P itself remains functionally uncharacterized and is not therapeutically actionable[2].

Other names
RN7SL607P7SL RNA pseudogene7SL RNA-like pseudogene
02

Biological functions

Other (pseudogenes may regulate parental gene expression via RNA-based mechanisms)
03

Disease associations

Other (pseudogenes can be implicated in disease processes such as cancer, but RN7SL607P itself lacks specific evidence)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 607, pseudogene (RN7SL607P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 607, pseudogene (RN7SL607P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call